PharmaCyte Biotech (PMCB) had the highest return in 2008 by a US stock in the Nasdaq Composite (IXIC), returning 27,947.6%.

ASSET	YEAR	% RETURN
PharmaCyte Biotech (PMCB)	2008	27,947.62%
Oxley Bridge Acquisition Limited Class A Ordinary Shares (OBA)	2008	5,749.06%
TOMI Environmental Solutions (TOMZ)	2008	1,650%
LifeMD (LFMD)	2008	1,483.33%
INVO Fertility (IVF)	2008	1,275%
Quantum Computing (QUBT)	2008	1,250%
Versus Systems Inc. (VS)	2008	668%
374Water Inc Common Stock (SCWO)	2008	471.43%
Sanara Medtech (SMTI)	2008	231.68%
Duos Technologies (DUOT)	2008	160%
Ammo (POWW)	2008	150%
Where Food Comes From (WFCF)	2008	114.29%
Axogen (AXGN)	2008	111.54%
Intrusion (INTZ)	2008	94.44%
Maywood Acquisition Corp Class A Ordinary Shares (MAYA)	2008	88.89%
Grand Canyon Education (LOPE)	2008	87.8%
Republic Bancorp (RBCAA)	2008	69.56%
Dollar Tree (DLTR)	2008	60.88%
Sapiens International (SPNS)	2008	60.02%
Mawson Infrastructure (MIGI)	2008	60%
Royal Gold (RGLD)	2008	58.98%
Univest Corporation Pennsylvania (UVSP)	2008	57.28%
Oramed Pharmaceuticals (ORMP)	2008	56%
Towne Bank (TOWN)	2008	55.37%
Capitol Federal Financial (CFFN)	2008	54.8%